Born P, Rosch T, Bruhl K, Ulm K, Sandschin W, Frimberger E, Allescher H, Classen M
II. Medizinische Klinik, Klinikum rechts der Isar, Technische Universitat München, Germany.
Hepatogastroenterology. 1998 May-Jun;45(21):833-9.
BACKGROUND/AIMS: Endoscopic stenting has become an established method of providing palliative treatment in cases of malignant biliary obstruction, as well as in benign biliary stenosis. Several problems associated with the types of stent used have not yet been resolved, and an ideal stent has yet to be designed. Observation of the clinical course for patients with biliary obstruction of various etiologies, and evaluation of the results with various treatment methods are the aims of this study.
In 1993 and 1994, biliary obstruction was treated endoscopically in 47 patients with a malignant pancreatic tumor and in 18 patients with chronic pancreatitis. The primary intervention was assessed retrospectively on the basis of the patients' records, and information concerning the clinical course was obtained by contacting the patients or their relatives or general practitioners.
Primary endoscopic drainage was successful in all cases. Only one of the patients with pancreatic tumors is still alive; survival after stent placement averaged 6.2 months. Metal stents remained patent significantly longer than plastic stents and percutaneous transhepatic biliary drains (PTBDs)(8.2 versus 3.5 or 1.9 months; p < 0.001). In cases of chronic pancreatitis, three of the nine patients who received only endoscopic treatment, without stenting, were able to continue without stents in the longer term, whereas seven of the nine who underwent surgery had no further problems.
Endoscopic drainage of biliary obstruction provides excellent short-term results. In long-term treatment for purely palliative purposes, metal stents remain patent for longer than plastic stents. In chronic pancreatitis, surgical treatment clearly seems to provide better long-term results than endoscopic therapy.
背景/目的:内镜支架置入术已成为恶性胆管梗阻及良性胆管狭窄姑息治疗的既定方法。与所用支架类型相关的几个问题尚未解决,理想的支架尚未设计出来。观察各种病因所致胆管梗阻患者的临床病程,并评估各种治疗方法的效果是本研究的目的。
1993年和1994年,对47例恶性胰腺肿瘤患者和18例慢性胰腺炎患者进行了内镜下胆管梗阻治疗。根据患者记录对初次干预进行回顾性评估,并通过联系患者或其亲属或全科医生获取有关临床病程的信息。
所有病例初次内镜引流均成功。仅1例胰腺肿瘤患者仍存活;支架置入后的平均生存期为6.2个月。金属支架的通畅时间明显长于塑料支架和经皮经肝胆道引流管(PTBD)(8.2个月对3.5个月或1.9个月;p<0.001)。在慢性胰腺炎病例中,9例仅接受内镜治疗而未置入支架的患者中有3例能够长期无需支架,而9例接受手术的患者中有7例没有进一步问题。
内镜下胆管梗阻引流术短期效果良好。在单纯姑息性的长期治疗中,金属支架的通畅时间比塑料支架长。在慢性胰腺炎中,手术治疗显然比内镜治疗能提供更好的长期效果。